OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Advances in Lung Transplant
Submission Deadline: May 30, 2023 (Open) Submit Now
Shambhu Aryal, MD,FCCP
Inova Advanced Lung Disease an Lung Transplant Program, Inova Fairfax Medical Campus, 3300 Gallows Road, Falls Church, VA 22042, USA
Research Interests: Lung Transplantation; Interstitial Lung Disease; Sarcoidosis; Pulmonary Hypertension; Cystic Fibrosis
About This Topic
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation. This is seeking original manuscripts for a Special Issue on: “Advances in Lung Transplant” scheduled to appear in the first half of 2023.
Lung transplantation is an established life-saving treatment for select patients who have failed conventional conservative medical therapy for their lung disease. After the first successful surgery in the early 1980s, the number of lung transplantations performed worldwide has increased steadily to about 5000 transplants per year. This increase in numbers has enriched the experience of the lung transplant community and led to several advances in the field. Improvement in surgical techniques and peri-operative management in the first couple of decades of lung transplantation led to improvement in early post-transplant survival. More recently, a lot of interest and resources are being put into important areas including primary graft dysfunction, organ preservation and rehabilitation, biomarkers in lung transplantation, antibody mediated rejection, and chronic lung allograft dysfunction. These works are expected to significantly improve both short-term and long-term outcomes including survival and quality of life for lung transplant recipient.
The special issue will provide a forum for presenting current research works and clinical results showing advancement in the field of lung transplantation noted above. The special issue will also be open to any author. Each submission will be reviewed by at least two reviewers to ensure a very high quality of papers selected for the Special Issue.
Lung transplantation; Acute cellular rejection; Antibody mediated rejection; Primary graft dysfunction; Donor derived cell-free DNA; Biomarkers for lung transplantation; Chronic lung allograft dysfunction; Bronchiolitis obliterans syndrome; Restrictive allograft syndrome; Extracorporeal photopheresis
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (email@example.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
Received: 25 May 2023; Published: 20 February 2024; doi: 10.21926/obm.transplant.2401207
Chronic allograft dysfunction (CLAD) is one of the leading causes of death after lung transplantation . CLAD is a progressive and irreversible decline in lung function after transplant, manifested as an obstructive, restrictive, or mixed ventilatory impairment without any identifiable etiology as infection or acute rejection [...]
by Shefali Mody , Soham Nadkarni , Shreyash Vats , Akshay Kumar , Sravanthi Nandavaram and Suresh Keshavamurthy
Received: 09 July 2023; Published: 23 November 2023; doi: 10.21926/obm.transplant.2304203
The shortage of donor lungs for transplantation is a major challenge, resulting in longer waitlist times for patients with a higher risk of waitlist mortality. It is crucial to continue promoting awareness about organ donation through legislation, public campaigns, and health care provider education. Only a small number of cadaveric donors [...]
Received: 07 August 2023; Published: 11 October 2023; doi: 10.21926/obm.transplant.2304197
Lung transplantation is a last-resort treatment option for patients with end stage lung disease. The procedure is being performed more frequently and scientific advances continue to be made, but the median post-transplant survival is far shorter than other solid organ transplant recipients. Candidate selection is a resource intensive process [...]
Lung Transplantation for COVID-19 Related Lung Disease: A Follow-Up Study of Outcomes from a Medium-Size Lung Transplant Programd
by Domingo Franco-Palacios , Lisa Allenspach , Lisa Stagner , Kelly Bryce , Jane Simanovski and Hassan Nemeh
Received: 01 May 2023; Published: 17 July 2023; doi: 10.21926/obm.transplant.2303193
In the United States of America, COVID-19 acute respiratory distress syndrome (ARDS) and post-COVID pulmonary fibrosis (PCPF) are raising indications for lung transplant (LT). Another indication for LT is underlying fibrosis with SARS-CoV-2 induced interstitial lung disease exacerbation or rapid progressing fibrosis. Only a few centers have [...]
Biomarkers in the Management of the Lung Transplant Allograft: A Focus on Donor-derived Cell-free DNA
Received: 16 March 2023; Published: 26 June 2023; doi: 10.21926/obm.transplant.2302190
Advances in the use of molecular biomarkers to guide management of lung transplant recipients are emerging. One such biomarker, donor-derived cell-free DNA (dd-cfDNA), has the potential to alter traditional approaches of lung transplant management, including the detection of acute rejection or infection, surveillance monitoring [...]
Received: 11 January 2023; Published: 04 April 2023; doi: 10.21926/obm.transplant.2302179
A boundless spectrum of chronic lung diseases is said to effect over 500 million persons globally. Lung transplantation is a well-established therapeutic option for patients suffering from end-stage lung diseases, however waitlist mortality and primary graft failure remain major determinants as post-transplantation 5-year survival is just [...]
by Ashwini Arjuna , Deepika Razia , Devika Sindu , Michael T. Olson , Lara Schaheen , Ross M. Bremner , Rajat Walia and Kendra McAnally
Received: 25 October 2022; Published: 06 January 2023; doi: 10.21926/obm.transplant.2301173
Few reports have described successful lung transplantation from a donor with a history of SARS-CoV-2 infection, and outcomes beyond 3 to 6 months remain unknown. After weighing the urgency and life-saving benefits of lung transplantation against the risk of viral transmission, we successfully performed a bilateral lung transplant from a donor [...]